4.2 Article

High-Resolution Computed Tomographic Imaging of Airways in Sarcoidosis Patients With Airflow Obstruction

Journal

JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY
Volume 32, Issue 6, Pages 905-912

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/RCT.0b013e31815b63dd

Keywords

airflow obstruction; airways; computed tomography; sarcoidosis

Ask authors/readers for more resources

Objective: To investigate airway involvement in patients with pulmonary sarcoidosis and airflow obstruction (AO) using high-resolution computed tomography Methods: Forty-two sarcoidosis patients with AO and 42 matched sarcoidosis patients Without AO were retrospectively analyzed. High-resolution Computed tomographic patterns of airway involvement were bronchial distortion, peribronchovascular thickening, small airway obstruction, and bronchial compression by enlarged lymph nodes. Results: Interobserver agreement was good (kappa > 0.8). High-resolution computed tomographic patterns of airway involvement were found more frequently, scored higher, and were more often multiple (P < 0.05) in patients with AO than those without. Functional improvement tinder treatment was observed more frequently in patients with predominant peribronchovascular thickening compared with patients with predominant bronchial distortion (P < 0.03). Conclusions: In pulmonary sarcoidosis patients with AO, high-resolution computed tomography is a reliable tool to identify underlying airways involvements, which are often Multiple, and enables prediction of the therapeutic response.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Critical Care Medicine

Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase 3 trial

Jean-Marc Naccache, Stephane Jouneau, Morgane Didier, Raphael Borie, Marine Cachanado, Arnaud Bourdin, Martine Reynaud-Gaubert, Philippe Bonniaud, Dominique Israel-Biet, Gregoire Prevot, Sandrine Hirschi, Francois Lebargy, Sylvain Marchand-Adam, Nathalie Bautin, Julie Traclet, Emmanuel Gomez, Sylvie Leroy, Frederic Gagnadoux, Frederic Riviere, Emmanuel Bergot, Anne Gondouin, Elodie Blanchard, Antoine Parrot, Francois-Xavier Blanc, Alexandre Chabrol, Stephane Dominique, Aude Gibelin, Abdellatif Tazi, Laurence Berard, Pierre Yves Brillet, Marie-Pierre Debray, Alexandra Rousseau, Mallorie Kerjouan, Olivia Freynet, Marie-Christine Dombret, Anne-Sophie Gamez, Ana Nieves, Guillaume Beltramo, Jean Pastre, Aurelie Le Borgne-Krams, Tristan Degot, Claire Launois, Laurent Plantier, Lidwine Wemeau-Stervinou, Jacques Cadranel, Cecile Chenivesse, Dominique Valeyre, Bruno Crestani, Vincent Cottin, Tabassome Simon, Hilario Nunes

Summary: The efficacy of cyclophosphamide in patients with acute exacerbation of idiopathic pulmonary fibrosis (IPF) is uncertain. The study suggests that adding cyclophosphamide to glucocorticoids increases the 3-month mortality rate in these patients.

LANCET RESPIRATORY MEDICINE (2022)

Article Medicine, Research & Experimental

Treatment of Idiopathic Pulmonary Fibrosis with Capsule or Tablet Formulations of Pirfenidone in the Real-Life French RaDiCo-ILD Cohort

Vincent Cottin, Sonia Gueguen, Hilario Nunes, Stephane Jouneau, Bruno Crestani, Philippe Bonniaud, Lidwine Wemeau, Dominique Israel-Biet, Martine Reynaud-Gaubert, Anne Gondouin, Jacques Cadranel, Sylvain Marchand-Adam, Marie Chevereau, Isabelle Dufaure-Gare, Serge Amselem, Annick Clement

Summary: This study in France on IPF patients using pirfenidone capsules and tablets showed good acceptability of the tablet formulation among patients, suggesting possible advantages over the capsules. The study highlighted no new adverse events and lower discontinuation rates in the tablet and substitution subgroups compared to the capsules-only subgroup.

ADVANCES IN THERAPY (2022)

Article Surgery

Determinants of survival after lung transplantation in telomerase-related gene mutation carriers: A retrospective cohort

Mathilde Phillips-Houlbracq, Herve Mal, Vincent Cottin, Clement Gauvain, Fabian Beier, Flore Sicre de Fontbrune, Sabrina Sidali, Jean Francois Mornex, Sandrine Hirschi, Antoine Roux, Gaelle Weisenburger, Arnaud Roussel, Lidwine Wemeau-Stervinou, Jerome Le Pavec, Christophe Pison, Sylvain Marchand Adam, Antoine Froidure, Romain Lazor, Jean-Marc Naccache, Stephane Jouneau, Hilario Nunes, Martine Reynaud-Gaubert, Aurelie Le Borgne, David Boutboul, Ibrahima Ba, Catherine Boileau, Bruno Crestani, Caroline Kannengiesser, Raphael Borie

Summary: This study reviewed the outcomes after lung transplantation in carriers of TRG gene mutations, identifying myelodysplasia and short telomeres as predictors of post-LT survival. All patients experienced anemia, with 66% having thrombocytopenia and 39% having neutropenia post-LT. Hematological evaluation should be conducted systematically before lung transplantation to improve outcomes.

AMERICAN JOURNAL OF TRANSPLANTATION (2022)

Editorial Material Oncology

Pitfalls in Cancer Evaluation in Case of Chronic Superior Vena Cava Obstruction: Vertebral Enhancement and Hot Quadrate Sign in the Liver

Julie Lasvergnas, Margot Playe, Laura Saint-Val, Pierre-Yves Brillet, Michael Soussan, Boris Duchemann

JOURNAL OF THORACIC ONCOLOGY (2022)

Article Respiratory System

Interstitial lung diseases associated with mutations of poly(A)-specific ribonuclease: A multicentre retrospective study

Quentin Philippot, Caroline Kannengiesser, Marie Pierre Debray, Clement Gauvain, Ibrahima Ba, Margherita Vieri, Anne Gondouin, Jean-Marc Naccache, Martine Reynaud-Gaubert, Yurdagul Uzunhan, Benjamin Bondue, Dominique Israel-Biet, Philippe Dieude, Cecile Fourrage, Elodie Lainey, Effrosyne Manali, Spyros Papiris, Lidwine Wemeau, Sandrine Hirschi, Herve Mal, Hilario Nunes, Frederic Schlemmer, Elodie Blanchard, Fabian Beier, Vincent Cottin, Bruno Crestani, Raphael Borie

Summary: This study describes the phenotype of patients with interstitial lung disease (ILD) and heterozygous PARN mutations, showing that idiopathic pulmonary fibrosis is common among individuals with PARN mutation. Other ILD subtypes may also be observed, and some patients may experience disease progression leading to death or lung transplantation despite specific treatment.

RESPIROLOGY (2022)

Article Immunology

Overexpression of IgG2 in patients resembling IgG4-related disease with normal IgG4

Mathilde Lecuit, Pierre Aucouturier, Aicha Abbas, Jacques Cadranel, Christine Silvain, Jean-Marie Berthelot, Anne-Laure Fauchais, Paul Loubet, Claude Bachmeyer, Francoise Montravers, Antoine Dossier, Hilario Nunes, Pascale Cervera, Paul Coppo

Summary: IgG4-related disease is characterized by tissue infiltration leading to fibrosis and organomegaly, with clinical presentation varying widely. High serum IgG4 concentration, previously considered a diagnostic hallmark, may not always be present in patients. Elevated IgG2, IgG1, and IgG3 levels were observed in some cases, underscoring the complexity of diagnosing IgG4-RD.

SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2022)

Article Respiratory System

Exposure to inorganic particles in paediatric sarcoidosis: the PEDIASARC study

Nadia Nathan, Marie-Emeline Montagne, Odile Macchi, Paul-Andre Rosental, Simon Chauveau, Florence Jeny, Lucile Sese, Rola Abou Taam, Manon Brocvielle, Jacques Brouard, Mickael Catinon, Catherine Chapelon-Abric, Fleur Cohen-Aubart, Christophe Delacourt, Celine Delestrain, Antoine Deschildre, Antoine Dossier, Ralph Epaud, Julien Haroche, Veronique Houdouin, Dominique Israel-Biet, Karine Juvin, Sylvain Le Jeune, Francois Lionnet, Ulrich Meinzer, Marie Mittaine, Hilario Nunes, Sarah Mattioni, Jean-Marc Naccache, Marie-Helene Odievre, Michel Vincent, Annick Clement, Dominique Valeyre, Catherine Cavalin

Summary: The study found that pediatric sarcoidosis is associated with patients' indirect exposure to inorganic particles, their family members' occupations, and heating sources, especially factors like construction and metal dust which may increase the risk of the disease.

THORAX (2022)

Article Cardiac & Cardiovascular Systems

Prevalence and Disease Spectrum of Extracoronary Arterial Abnormalities in Spontaneous Coronary Artery Dissection

Alexandre Persu, Marilucy Lopez-Sublet, Abtehale Al-Hussaini, Marco Pappaccogli, Ibtissem Radhouani, Patricia van der Niepen, William Adair, Christophe Beauloye, Pierre-Yves Brillet, Nathan Chan, Patrick Chenu, Hannes Devos, Javier Escaned, Marcos Garcia-Guimaraes, Frank Hammer, Robert Jackson, Salma Jebri, Deevia Kotecha, Fernando Macaya, Ciara Mahon, Nalin Natarajan, Kandiyil Neghal, Edward D. Nicol, Kelly S. Parke, Diluka Premawardhana, Averachan Sajitha, Joanne Wormleighton, Nilesh J. Samani, Gerry P. McCann, David Adlam

Summary: In this study, the prevalence of FMD in patients with SCAD was found to be 31.8%, with involvement of multiple vascular beds also being common. However, the prevalence and degree of arterial tortuosity were similar in patients and controls. This suggests that extracoronary vascular events appear to be rare in SCAD patients.

JAMA CARDIOLOGY (2022)

Article Respiratory System

WASOG statement on the diagnosis and management of sarcoidosis-associated pulmonary hypertension

Laurent Savale, Marloes Huitema, Oksana Shlobin, Vasilis Kouranos, Steven D. Nathan, Hiliaro Nunes, Rohit Gupta, Jan C. Grutters, Daniel A. Culver, Marco C. Post, Daniel Ouellette, Elyse E. Lower, Tamara Al-Hakim, Athol U. Wells, Marc Humbert, Robert P. Baughman

Summary: Sarcoidosis-associated pulmonary hypertension (SAPH) is a significant complication of advanced sarcoidosis. A task force was established to summarize the current knowledge and provide guidance for patient management, including screening and diagnosis. The committee has developed consensus regarding screening and further testing, as well as the need for joint decision-making with experts in sarcoidosis and pulmonary hypertension for specific treatment. However, there are still significant knowledge gaps regarding SAPII that need to be addressed in future studies.

EUROPEAN RESPIRATORY REVIEW (2022)

Article Rheumatology

Sarilumab in adults hospitalised with moderate-to-severe COVID-19 pneumonia (CORIMUNO-SARI-1): An open-label randomised controlled trial

France X. Mariette, O. Hermine, P-L Tharaux, M. Resche-Rigon, R. Porcher, P. Ravaud

Summary: Treatment with sarilumab did not improve early outcomes in patients with moderate-to-severe COVID-19 pneumonia. Further studies are warranted to evaluate the effect of sarilumab on long-term survival.

LANCET RHEUMATOLOGY (2022)

Review Medicine, General & Internal

Comorbidities of sarcoidosis

Claudio Tana, Marjolein Drent, Hilario Nunes, Vasilis Kouranos, Francesco Cinetto, Naomi T. Jessurun, Paolo Spagnolo

Summary: Sarcoidosis is a heterogeneous disease that can affect various organs, and its interaction and coexistence with other diseases can complicate diagnosis and treatment.

ANNALS OF MEDICINE (2022)

Letter Respiratory System

Extracorporeal life support allows lung transplant in anti-MDA5+rapidly progressive interstitial lung disease

Pierre Bay, Marc Pineton de Chambrun, Antoine Roux, Vincent Bunel, Alain Combes, Dominique Israel-Biet, Benjamin Zuber, Hilario Nunes, Yves Allenbach, Yurdagul Uzunhan

EUROPEAN RESPIRATORY JOURNAL (2022)

Article Cardiac & Cardiovascular Systems

Diagnosis Yield and Safety of Surgical Biopsy in Interstitial Lung Diseases: A Prospective Study

Dana Radu, Olivia Freynet, Marianne Kambouchner, Marouane Boubaya, Hilario Nunes, Yurdagul Uzunhan, Pierre-Yves Brillet, Patrice Guiraudet, Mohammad Zaahid Noorah, Dominique Israel-Biet, Francoise Le Pimpec-Barthes, Karine Juvin, Anne Charpentier, Laure Gibault, Jalal Assouad, Jean-Marc Naccache, Martine Antoine, Sebastian Tavolaro, Marco Alifano, Isabelle Honore, Jean Pierre L'Huillier, Denis Debrosse, Clairelyne Dupin, Pauline Pradere, Marie-Pierre Debray, Aurelie Cazes, Pierre Mordant, Yves Castier, Sadek Beloucif, Bruno Crestani, Vincent Levy, Emmanuel Martinod, Dominique Valeyre

Summary: This study prospectively assessed the yield of diagnosis and safety of video-assisted thoracoscopic surgical lung biopsy (VATS-LB) for ILD diagnosis in 103 patients. The results showed that VATS-LB dramatically changed preoperative hypothetical diagnoses and treatment in ILD of unknown cause.

ANNALS OF THORACIC SURGERY (2022)

Article Rheumatology

Anti-PM-Scl antibodies-positive patients encompass three different groups with distinct prognoses

Paul Breillat, Kuberaka Mariampillai, Paul Legendre, Pauline Martins, Bertrand Dunogue, Jean Luc Charuel, Makoto Miyara, Claire Goulvestre, Romain Paule, Helene Vanquaethem, Felix Ackermann, Olivier Benveniste, Hilario Nunes, Luc Mouthon, Yves Allenbach, Yurdagul Uzunhan

Summary: This study identified three distinct clinical phenotypes and outcomes among patients with anti-PM-Scl-scleroderma antibodies positive autoimmune diseases. Skin thickening and non-specific interstitial pneumonia were crucial predictors in differentiating these subgroups.

RHEUMATOLOGY (2023)

Proceedings Paper Engineering, Biomedical

Multiparameter analysis of vascular remodeling in post-acute sequelae of COVID-19

Catalin Fetita, Mathilde Maury, Aurelien Justet, Juliette Dindart, Jean Richeux, Lucile Sese, Nicolas Aide, Thomas Gille, Hilario Nunes, Jean-Francois Bernaudin, Pierre-Yves Brillet

Summary: The study investigates the existence of residual vascular alteration in post-acute sequelae of COVID-19 (PASC) by analyzing associations between vascular remodeling biomarkers extracted from CT and functional, radiological, and morphological parameters. The results suggest moderate to strong correlations between the biomarkers and the persistence of vascular alterations in PASC, highlighting a promising direction for future research in understanding the development of fibrotic patterns.

MEDICAL IMAGING 2022: COMPUTER-AIDED DIAGNOSIS (2022)

No Data Available